1. Home
  2. MTEK vs OSRH Comparison

MTEK vs OSRH Comparison

Compare MTEK & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maris-Tech Ltd.

MTEK

Maris-Tech Ltd.

HOLD

Current Price

$1.40

Market Cap

12.6M

Sector

N/A

ML Signal

HOLD

Logo OSR Holdings Inc.

OSRH

OSR Holdings Inc.

HOLD

Current Price

$0.52

Market Cap

11.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTEK
OSRH
Founded
2008
N/A
Country
Israel
United States
Employees
N/A
21
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
12.6M
11.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MTEK
OSRH
Price
$1.40
$0.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
216.6K
714.2K
Earning Date
03-27-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.03
$0.38
52 Week High
$4.27
$1.79

Technical Indicators

Market Signals
Indicator
MTEK
OSRH
Relative Strength Index (RSI) 44.31 51.86
Support Level $1.23 $0.41
Resistance Level $1.50 $0.74
Average True Range (ATR) 0.16 0.06
MACD -0.00 0.01
Stochastic Oscillator 48.96 50.65

Price Performance

Historical Comparison
MTEK
OSRH

About MTEK Maris-Tech Ltd.

Maris Tech Ltd is a business-to-business approach, or B2B provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.

About OSRH OSR Holdings Inc.

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

Share on Social Networks: